Vetr upgraded shares of Rite Aid (NYSE:RAD) from a hold rating to a strong-buy rating in a report issued on Tuesday. The brokerage currently has $2.54 price objective on the stock.
Several other research analysts have also recently weighed in on the company. Zacks Investment Research cut Rite Aid from a hold rating to a sell rating in a research report on Tuesday, January 9th. Evercore ISI assumed coverage on Rite Aid in a research report on Thursday, January 4th. They set an underperform rating and a $1.50 price objective for the company. Deutsche Bank assumed coverage on Rite Aid in a research report on Monday, December 4th. They set a hold rating and a $2.25 price objective for the company. Royal Bank of Canada set a $2.00 price objective on Rite Aid and gave the stock a hold rating in a research report on Wednesday, October 25th. Finally, Mizuho set a $2.00 price objective on Rite Aid and gave the stock a hold rating in a research report on Saturday, October 7th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $2.75.
Shares of Rite Aid (NYSE RAD) remained flat at $$2.31 during trading on Tuesday. The stock had a trading volume of 15,083,159 shares, compared to its average volume of 26,806,598. The company has a quick ratio of 0.59, a current ratio of 0.86 and a debt-to-equity ratio of 3.66. The company has a market capitalization of $2,465.95, a P/E ratio of 15.40 and a beta of 1.83. Rite Aid has a 1-year low of $1.38 and a 1-year high of $8.61.
ILLEGAL ACTIVITY WARNING: This story was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3147681/rite-aid-rad-upgraded-at-vetr.html.
About Rite Aid
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.